These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17472603)

  • 1. Effectiveness of kamishoyosan for premenstrual dysphoric disorder: open-labeled pilot study.
    Yamada K; Kanba S
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):323-5. PubMed ID: 17472603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
    Freeman EW; Rickels K; Sondheimer SJ
    J Clin Psychiatry; 1996; 57 Suppl 8():56-9; discussion 60. PubMed ID: 8698682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual depression with nortriptyline: a pilot study.
    Harrison WM; Endicott J; Nee J
    J Clin Psychiatry; 1989 Apr; 50(4):136-9. PubMed ID: 2647713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.
    Hsiao CC; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):593-9. PubMed ID: 15601382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols.
    Wu KY; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2008 Feb; 62(1):109-14. PubMed ID: 18289149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):610-2. PubMed ID: 16194267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.
    Gonda X; Telek T; Juhász G; Lazary J; Vargha A; Bagdy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1782-8. PubMed ID: 18721843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes.
    Yonkers KA
    Psychopharmacol Bull; 2003; 37 Suppl 1():135-47. PubMed ID: 14566208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-day gradual reduction regimen of chlormadinone reduces premenstrual anxiety and depression: a pilot study.
    Contreras CM; Azamar-Arizmendi G; Saavedra M; Hernández-Lozano M
    Arch Med Res; 2006 Oct; 37(7):907-13. PubMed ID: 16971235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan in the treatment of late luteal phase dysphoric disorder: a pilot study.
    Steinberg S; Annable L; Young SN; Bélanger MC
    J Psychiatry Neurosci; 1994 Mar; 19(2):114-9. PubMed ID: 8204563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acupuncture on the symptoms of anxiety and depression caused by premenstrual dysphoric disorder.
    Carvalho F; Weires K; Ebling M; Padilha Mde S; Ferrão YA; Vercelino R
    Acupunct Med; 2013 Dec; 31(4):358-63. PubMed ID: 24029029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on urinary metabolomics of premenstrual dysphoric disorder patients with liver-qi depression syndrome treated with Xiaoyaosan: Study Protocol Clinical Trial (SPIRIT Compliant).
    Xu M; Liu Y; Guo Y; Liu C; Liu Y; Yan Z; Hou Y; Li X; Ma Q; Zhou X; Liu L; Huang S; Chen J
    Medicine (Baltimore); 2020 Apr; 99(16):e19425. PubMed ID: 32311921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kampo therapy for premenstrual syndrome: efficacy of Kamishoyosan quantified using the second derivative of the fingertip photoplethysmogram.
    Kimura Y; Takamatsu K; Fujii A; Suzuki M; Chikada N; Tanada R; Kume Y; Sato H
    J Obstet Gynaecol Res; 2007 Jun; 33(3):325-32. PubMed ID: 17578362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine for premenstrual dysphoric disorder: a pilot study.
    Mazza M; Harnic D; Catalano V; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Mar; 9(4):517-21. PubMed ID: 18312154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices.
    Ling FW
    J Clin Psychiatry; 2000; 61 Suppl 12():9-16. PubMed ID: 11041379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual dysphoric disorder and changes in frontal alpha asymmetry.
    Baehr E; Rosenfeld P; Miller L; Baehr R
    Int J Psychophysiol; 2004 Apr; 52(2):159-67. PubMed ID: 15050374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series.
    Ravindran LN; Woods SA; Steiner M; Ravindran AV
    Arch Womens Ment Health; 2007; 10(3):125-7. PubMed ID: 17431739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
    Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
    J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Clin Neuropharmacol; 2009; 32(1):6-9. PubMed ID: 19471183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.